Importance of providing cardiologists with useful advice on herb-drug interactions

Journal of the American College of Cardiology

Volumn 56, Issue 11, 2010, Pages 903-904

  Dentali, Steven ^a  

^a American Herbal Products Association   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLOGIST; DOCTOR PATIENT RELATION; HERB DRUG INTERACTION; HERBAL MEDICINE; HUMAN; LETTER; PATIENT EDUCATION; PRIORITY JOURNAL; RISK FACTOR; PHYTOTHERAPY;

PLANT MEDICINAL PRODUCT;

HERB-DRUG INTERACTIONS; HUMANS; PHYSICIAN-PATIENT RELATIONS; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 77956318451     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.03.074     Document Type: Letter

References (12)

1. A. Tachjian, V. Maria, and A. Jahangir Use of herbal products and potential interactions in patients with cardiovascular diseases J Am Coll Cardiol 55 2010 515 525
2. American Herbal Products Association AHPA Guidance Policies http://www.ahpa.org/Portals/0/2009/10-0120-Guidance-Policies.pdf Accessed February 18, 2010
3. W. Li, Y. Sun, J.F. Fitzloff, and R.B. van Breemen Evaluation of commercial ginkgo and echinacea dietary supplements for colchicine using liquid chromatography-tandem mass spectrometry Chem Res Toxicol 15 2002 1174 1178
4. Therapeutic Goods Administration TGA questions validity of colchicine report October 11, 2001
5. K. Bone Ginkgo and colchicine: curiouser and curiouser, says Alicephytotherapy reviewcolchicine in placental blood Townsend Lett Doctors Patients 225 2002 143 144
6. D.V. Awang Maternal use of ginseng and neonatal androgenization JAMA 266 1991 363
7. D.V. Awang Siberian ginseng toxicity may be case of mistaken identity CMAJ 155 1996 1237
8. S. Wanwimolruk, K. Wong, and P. Wanwimolruk Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4 Drug Metabol Drug Interact 24 2009 17 35
9. B. Gurley, M.A. Hubbard, and D.K. Williams Assessing the clinical significance of botanical supplementation on human cytochrome P450 3A activity: comparison of a milk thistle and black cohosh product to rifampin and clarithromycin J Clin Pharmacol 46 2006 201 213
10. B.J. Gurley, S.F. Gardner, and M.A. Hubbard In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes Clin Pharmacol Ther 77 2005 415 426
11. S. Dentali Successful botanical research requires botanical expertise Clin Pharmacol Ther 87 2010 149 151
12. M. McGuffin, C. Hobbs, R. Upton, A. Goldberg, American Herbal Products Association's Botanical Safety Handbook 1997 CRC Press Boca Raton, FL